Systemic inflammatory biomarkers including high sensitivity C-reactive protein (hs-CRP), tumor necrosis factor α (TNF-α), and interleukin (IL)-6, have been identified as risk factors for both the onset and recurrence of AF after transcatheter ablation [13]. The gene discussed is TNF; the disease is atrial fibrillation.